AGENDA

Presentation Materials

Will open in a new window. 

Friday, October 6
1 pmKeynote Address: Evolving Trends in Psychopharmacology (Non-CME)
Hari Kannon, MD		No Slides Available
2 pm

Common Non-AD Dementias: How to Recognize and Treat Them
Heike Schmolck, MD, Mercy Ruan Neurology and Neuroscience Center

  • Differentiate symptoms of early AD from symptoms commonly seen in LBD and FTD, and understand their anatomical basis.
  • Improve diagnostic accuracy using history, exam findings, and imaging.
  • Develop a treatment plan for the respective conditions.

Slides

Slides with Note Pages

3:15 pm

Schizophrenia in Old Age
Maria Sonnack, MPAS, PA-C, Broadlawns Medical Center 

  • State recommendations for schizophrenia in the geriatric population.
  • Differentiate symptoms of schizophrenia in the elderly vs. alternate causes of psychosis.
  • List the risks vs. benefits of antipsychotic treatment in the geriatric population. 

Slides

Slides with Note Pages

4:15 pmTelehealth: Introduction and Application (Non-CME)
Kyle Savage		No Slides Available
Saturday, October 7
9 am

Depression in Older Adults
Ahmar Butt, MD, Broadlawns Medical Center 

  • List symptoms and causes of late-life depression in older adults.
  • Compare and contrast the presentation of depression in older patients to those of younger patients.
  • Treat mood disorders in aging adults. 

Slides

Slides with Note Pages

10:15 am

Behavioral Distrubances in Dementia
Yogesh Shah, MD, MPH, Broadlawns Medical Center

  • Identify factors precipitating behavioral disturbances.
  • Identify how to rule out medical, environmental, and caregiving causes of behavioral problems.
  • Discuss environmental and non-pharmacological management of behavioral disturbances.
  • Discuss when and how to medicate.

Slides

Slides with Note Pages

11:15 am

Psychiatric Pharmacogenomics: Introduction and Applications
Stephanie Ebner, PhD, Assurex Health 

  • Identify how commonly tested genes in psychiatric pharmacogenomics can impact medication efficacy, response, and side effects.
    • Illustrate the utility of integrating pharmacogenetic testing into clinical practice.
  • Analyze and evaluate available evidence for individual pharmacogenetic tests to ensure the product selected is clinically and economically useful, and clinically valid.

Slides

1 pm

Healthy Aging, Successful Aging
Robert Bender, MD, Broadlawns Medical Center

  • List the 10 pillars of optimal aging.
  • Develop insights into how lifestyle affects physical and mental health.
  • Develop insights into the concept of neuroplasticity.

Slides

Slides with Note Pages

2:15 pm

Anxiety Disorders in the Geriatric Population
Janice Landy, MD, Broadlawns Medical Center

  • Differentiate between various anxiety disorders.
  • List psychosocial and psychotherapeutic interventions used to treat anxiety disorders in the geriatric population.
  • Discuss risks and benefits of various medications used to treat anxiety disorders in the geriatric population. 

Slides

Slides with Note Pages

3:15 pm

Substance Use Disorders In the Geriatric Population
Michelle Davids, DO, Broadlawns Medical Center 

  • Define substance use disorders.
  • Identify ways in which to screen substance use disorders in the geriatric population.
  • List common substances of abuse or misuse.
  • Identify treatment options for substance use disorders in the geriatric population. 

Slides

Slides with Note Pages

Disclosures

The following speakers and planning committee members have no conflicts with commercial interests to disclose.

  • Robert Bender, MD, Actvity Director, Planning Committee, Speaker
  • Ahmar Butt, MD, Speaker
  • Michelle Davids, DO, Speaker
  • Janice Landy, MD, Speaker
  • Heike Schmolck, MD, Speaker
  • Sandra Scholten, Actvity Director, Planning Committee
  • Yogesh Shah, MD, MPH, Actvity Director, Planning Committee, Speaker
  • Maria Sonnack, MPAS, PA-C, Speaker

The following speakers and planning committee members have a conflict(s) with commercial interests to disclose.

  • Stephanie Ebner, PhD, Speaker - Employed as a Medical Affairs Manager by Assurex Health (a wholly owned subsidiary of Myriad Genetics). The DMU CME Director has reviewed the content and determined the presentation is without influence by a commercial interest company. 

The speakers will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration. Determination of educational content for this program and the selection of speakers are responsibilities of the activity director. Firms providing financial support did not have input in these areas.